Fig. 10.
Fig. 10. Flow cytometric analysis for TRAIL receptor expression on myeloma cells treated with the NF-κB inhibitor SN50. / Flow cytometric analysis was performed to determine the cell surface expression of TRAIL receptors DR4, DR5, DcR1, and DcR2 (shaded peaks) on MM.1S cells treated with and without the NF-κB inhibitor SN50 (30 μg/mL) for 6 hours. Isotype control antibody staining appears as unshaded peaks.

Flow cytometric analysis for TRAIL receptor expression on myeloma cells treated with the NF-κB inhibitor SN50.

Flow cytometric analysis was performed to determine the cell surface expression of TRAIL receptors DR4, DR5, DcR1, and DcR2 (shaded peaks) on MM.1S cells treated with and without the NF-κB inhibitor SN50 (30 μg/mL) for 6 hours. Isotype control antibody staining appears as unshaded peaks.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal